BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33746001)

  • 1. Chemical profile of Swertia mussotii Franch and its potential targets against liver fibrosis revealed by cross-platform metabolomics.
    Zhang Y; Zhou Q; Ding X; Ma J; Tan G
    J Ethnopharmacol; 2021 Jun; 274():114051. PubMed ID: 33746001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the Hepatoprotective Effect and Mechanism of Swertia mussotii Franch in an Acute Liver Injury Rat Model.
    Yun H; Duan X; Xiong W; Ding Y; Wu X; Kang J; Pu X; Yang Y; Chen Z
    Comb Chem High Throughput Screen; 2019; 22(9):649-656. PubMed ID: 31692440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swertia purpurascens Wall ethanolic extract mitigates hepatic fibrosis and restores hepatic hepcidin levels via inhibition of TGFβ/SMAD/NFκB signaling in rats.
    Raj D; Sharma V; Upadhyaya A; Kumar N; Joshi R; Acharya V; Kumar D; Patial V
    J Ethnopharmacol; 2022 Feb; 284():114741. PubMed ID: 34699946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolating the metabolic pathways involved in the hepatoprotective effect of Muntingia calabura against CCl4-induced liver injury using LC/MS Q-TOF.
    Rofiee MS; Yusof MI; Abdul Hisam EE; Bannur Z; Zakaria ZA; Somchit MN; Teh LK; Salleh MZ
    J Ethnopharmacol; 2015 May; 166():109-18. PubMed ID: 25792013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Profile Changes of CCl₄-Liver Fibrosis and Inhibitory Effects of Jiaqi Ganxian Granule.
    Wang G; Li Z; Li H; Li L; Li J; Yu C
    Molecules; 2016 May; 21(6):. PubMed ID: 27248993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Mechanism of Swertia mussotii Franch. for Hepatoprotective Effects with iTRAQ LC-MS/MS.
    Yun H; Wu X; Ding Y; Xiong W; Duan X; Gao H; Yang Y; Chen Z
    Comb Chem High Throughput Screen; 2021; 24(9):1332-1339. PubMed ID: 33081677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism.
    Wang C; Ma C; Fu K; Liu Y; Gong L; Peng C; Li Y
    J Ethnopharmacol; 2022 Oct; 296():115478. PubMed ID: 35716920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats.
    Feng XC; Du X; Chen S; Yue D; Cheng Y; Zhang L; Gao Y; Li S; Chen L; Peng Z; Yang Y; Luo W; Wang R; Chen W; Chai J
    Int J Clin Exp Pathol; 2015; 8(1):184-95. PubMed ID: 25755705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics study of the hepatoprotective effect of Phellinus igniarius in chronic ethanol-induced liver injury mice using UPLC-Q/TOF-MS combined with ingenuity pathway analysis.
    Dong Y; Qiu P; Zhao L; Zhang P; Huang X; Li C; Chai K; Shou D
    Phytomedicine; 2020 Aug; 74():152697. PubMed ID: 30392748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing the hepatoprotective effect of the Swertia cincta Burkillextract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes.
    Xu L; Sheng T; Liu X; Zhang T; Wang Z; Han H
    J Ethnopharmacol; 2017 Sep; 209():91-99. PubMed ID: 28734962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: An analysis of bile acids metabolic mechanism.
    Song YN; Zhang GB; Lu YY; Chen QL; Yang L; Wang ZT; Liu P; Su SB
    J Ethnopharmacol; 2016 Aug; 189():148-56. PubMed ID: 27196295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profiling of emodin drug-induced liver injury and silybin treatment in rats using ultra-performance liquid chromatography-quadrupole-time-of-flight-mass spectrometry: A metabolomic and mechanistic approach.
    Chen C; Qian J; Zhao X; Han X; Tang X; Gao J; Liu Y; Jiang J; Wen B
    Biomed Chromatogr; 2022 Nov; 36(11):e5469. PubMed ID: 35904380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatoprotective effect and chemical constituents of total iridoids and xanthones extracted from Swertia mussotii Franch.
    Tian C; Zhang T; Wang L; Shan Q; Jiang L
    J Ethnopharmacol; 2014 May; 154(1):259-66. PubMed ID: 24746481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profiling of endogenous bile acids: a novel method to assess hepatoprotective effect of Tanreqing capsule on carbon-tetrachloride-induced liver injury in rats.
    Xu Y; Zhong PP; Tao YY
    Chin J Nat Med; 2018 Apr; 16(4):271-283. PubMed ID: 29703327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic discrimination of Swertia mussotii and Swertia chirayita known as "Zangyinchen" in traditional Tibetan medicine by (1)H NMR-based metabolomics.
    Fan G; Luo WZ; Luo SH; Li Y; Meng XL; Zhou XD; Zhang Y
    J Pharm Biomed Anal; 2014 Sep; 98():364-70. PubMed ID: 24992216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radix Paeoniae Rubra and Radix Paeoniae Alba Attenuate CCl4-induced acute liver injury: an ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) based metabolomic approach for the pharmacodynamic study of Traditional Chinese Medicines (TCMs).
    Wang R; Xiong AZ; Teng ZQ; Yang QW; Shi YH; Yang L
    Int J Mol Sci; 2012 Nov; 13(11):14634-47. PubMed ID: 23203085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swertiamarin, an active iridoid glycoside from Swertia pseudochinensis H. Hara, protects against alpha-naphthylisothiocyanate-induced cholestasis by activating the farnesoid X receptor and bile acid excretion pathway.
    Shi M; Tang J; Zhang T; Han H
    J Ethnopharmacol; 2022 Jun; 291():115164. PubMed ID: 35278607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum metabonomics study of the hepatoprotective effect of amarogentin on CCl
    Zhang Y; Zhang M; Li H; Zhao H; Wang F; He Q; Zhang T; Wang S
    J Pharm Biomed Anal; 2018 Feb; 149():120-127. PubMed ID: 29112900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
    Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput targeted metabolomics method for the quantification of 104 non-polar metabolites in cholesterol, eicosanoid, and phospholipid metabolism: application in the study of a CCl
    Jia M; Peng Z; Yang K; Su C; Wang Y; Yan C
    Analyst; 2020 May; 145(10):3575-3591. PubMed ID: 32329491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.